Ischemic stroke market Research Report-  Global  Forecast till 2027

Ischemic stroke market research report: by diagnosis (CT, MRI, carotid ultrasound, cerebral angiography), drug class (tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive), surgery, end user – Global forecast till 2027

ID: MRFR/MED/3980-HCR | February 2021 | Region: Global | 120 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario:


Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.


The key strategies adopted by leading industry players incldues new product launches and collaborations. For instance, in April 2016, the novel TransCarotid Artery Revascularization (TCAR) procedure launched by Silk Road Medical, Inc, received FDA approval. This minimally invasive technique is designed to access the common carotid artery. Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval.


Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market. High cost of the surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth.


The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.


Research Methodology:


 Research Methodology


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience:



  • Ischemic Stroke Drug Suppliers

  • Ischemic Stroke Drug Manufacturers

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Segmentation:


The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users.


On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.


On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others


On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy


On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.


Regional Analysis:                     


The global ischemic stroke market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.


The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014.


Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe


Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.


The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector.


Key Players:


The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the new players in the global ischemic stroke market. Additionally, emerging markets, such as India and China, could also open new opportunities to new players.


Some of key the players in the Americas ischemic stroke market are Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.),  Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.),  Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.),  GE Healthcare (U.S.),  Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others



TABLE OF CONTENT


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Surgery Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 7. Global Ischemic Stroke Market, By Diagnosis

7.1 Introduction

7.2 Computed Tomography (CT)

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.3 Magnetic Resonance Imaging (MRI)

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 Carotid Ultrasound

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Cerebral Angiography

7.5.1 Market Estimates & Forecast, 2020 – 2027

7.6 Electrocardiography

7.7.1 Market Estimates & Forecast, 2020 – 2027

7.8 Echocardiography

7.8.1 Market Estimates & Forecast, 2020 – 2027

7.4 Others

Chapter 8. Global Ischemic Stroke Market, By Drug Class

8.1 Introduction

8.2 Tissue Plasminogen Activator

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Anticoagulant

8.3.1 Market Estimates & Forecast, 2020 – 2027

8.4 Antiplatelet

8.4.1 Market Estimates & Forecast, 2020 – 2027

8.5 Antihypertensive

8.5.1 Market Estimates & Forecast, 2020 – 2027

8.6 Others

Chapter 9. Global Ischemic Stroke Market, By Surgery

9.1 Introduction

9.2 Carotid Endarterectomy

9.2.1 Market Estimates & Forecast, 2020 – 2027

9.3 Angioplasty

9.3.1 Market Estimates & Forecast, 2020 – 2027

9.4 Endovascular Mechanical Thrombectomy

9.4.1 Market Estimates & Forecast, 2020 – 2027

Chapter 10. Global Ischemic Stroke Market, By End User

10.1 Introduction

10.2 Hospitals & Clinics

10.2.1 Market Estimates & Forecast, 2020 – 2027

10.3 Medical Institutes

10.3.1 Market Estimates & Forecast, 2020 – 2027

10.4 Research Organization

10.4.1 Market Estimates & Forecast, 2020 – 2027

10.5 Others

10.5.1 Market Estimates & Forecast, 2020 – 2027

Chapter. 11 Global Ischemic Stroke Market, By Region

11.1 Introduction

11.2 Americas

11.2.1 North America

11.2.1.1 U.S.

11.2.1.2 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 U.K

11.3.1.6 Rest Of Western Europe

11.3.2 Eastern Europe

11.4 Asia Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 Republic Of Korea

11.4.6 Rest Of Asia Pacific

11.5 The Middle East & Africa

11.5.1 United Arab Emirates

11.5.2 Saudi Arabia

11.5.3 Rest Of The Middle East & Africa

Chapter 12 Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

12.3.1 Key Developments

Chapter 13 Company Profiles

13.1 Abbott Laboratories

13.1.1 Company Overview

13.1.2 Drug Class Overview

13.1.3 Financials

13.1.4 SWOT Analysis

13.2 Medtronic Plc

13.2.1 Company Overview

13.2.2 Drug Class Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 Boston Scientific Corporation

13.3.1 Company Overview

13.3.2 Drug Class Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Cordis Corporation

13.4.1 Company Overview

13.4.2 Drug Class/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Merck & Co., Inc.

13.5.1 Company Overview

13.5.2 Drug Class Overview

13.5.3 Financial Overview

13.5.4 Key Developments

13.6 Koninklijke Philips N.V.

13.6.1 Company Overview

13.6.2 Drug Class Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.7 GE Healthcare

13.7.1 Overview

13.7.2 Drug Class Overview

13.7.3 Financials

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 Stryker Corporation

13.8.1 Company Overview

13.8.2 Drug Class/Business Segment Overview

13.8.3 Financial Overview

13.8.4 Key Development

13.8.5 SWOT Analysis

13.9 Pfizer Inc.

13.9.1 Company Overview

13.9.2 Drug Class Overview

13.9.3 Financial Overview

13.9.4 Key Developments

13.10 Others

Chapter 14 MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO’s View Point

14.1.2 Unmet Needs Of The Market

14.2 Key Companies To Watch

14.3 Prediction Of Pharmaceutical Industry

Chapter 15 Appendix


LIST OF TABLES


Table 1 Ischemic Stroke Industry Synopsis, 2020 – 2027

Table 2 Ischemic Stroke Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Ischemic Stroke Market By Region, 2020 – 2027, (USD Million)

Table 4 Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 5 Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 6 Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 7 Ischemic Stroke Market By End Users, 2020 – 2027, (USD Million)

Table 8 North America Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 9 North America Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 10 North America Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 11 North America Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 12 US Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 13 US Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 14 US Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 15 US Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 16 Canada Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 17 Canada Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 18 Canada Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 19 Canada Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 20 South America Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 21 South America Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 22 South America Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 23 South America Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 24 Europe Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 25 Europe Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 26 Europe Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 27 Europe Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 28 Western Europe Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 29 Western Europe Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 30 Western Europe Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 31 Western Europe Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 34 Eastern Europe Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 38 Asia Pacific Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)

Table 40 The Middle East & Africa Ischemic Stroke Market By Diagnosis, 2020 – 2027, (USD Million)

Table 41 The Middle East & Africa Ischemic Stroke Market By Drug Class, 2020 – 2027, (USD Million)

Table 42 The Middle East & Africa Ischemic Stroke Market By Surgery, 2020 – 2027, (USD Million)

Table 43 The Middle East & Africa Ischemic Stroke Market By End User, 2020 – 2027, (USD Million)



LIST OF FIGURES


Figure 1 Research Process

Figure 2 Segmentation For Ischemic Stroke Market

Figure 3 Segmentation Market Dynamics For Ischemic Stroke Market

Figure 4 Global Ischemic Stroke Market Share, By Diagnosis 2020

Figure 6 Global Ischemic Stroke Market Share, By Drug Class 2020

Figure 7 Global Ischemic Stroke Market Share, By Surgery, 2020

Figure 8 Global Ischemic Stroke Market Share, By End Users, 2020

Figure 9 Global Ischemic Stroke Market Share, By Region, 2020

Figure 10 North America Ischemic Stroke Market Share, By Country, 2020

Figure 11 Europe Ischemic Stroke Market Share, By Country, 2020

Figure 12 Asia Pacific Ischemic Stroke Market Share, By Country, 2020

Figure 13 The Middle East & Africa Ischemic Stroke Market Share, By Country, 2020

Figure 14 Global Ischemic Stroke Market: Company Share Analysis, 2020 (%)

Figure 15 Abbott Laboratories: Key Financials

Figure 16 Abbott Laboratories: Segmental Revenue

Figure 17 Abbott Laboratories: Geographical Revenue

Figure 18 Medtronic Plc: Key Financials

Figure 19 Medtronic Plc: Segmental Revenue

Figure 20 Medtronic Plc: Geographical Revenue

Figure 21 Boston Scientific Corporation: Key Financials

Figure 22 Boston Scientific Corporation: Segmental Revenue

Figure 23 Boston Scientific Corporation: Geographical Revenue

Figure 24 Cordis Corporation: Key Financials

Figure 25 Cordis Corporation: Segmental Revenue

Figure 26 Cordis Corporation: Geographical Revenue

Figure 27 Merck & Co., Inc.: Key Financials

Figure 28 Merck & Co., Inc.: Segmental Revenue

Figure 29 Merck & Co., Inc.: Geographical Revenue

Figure 30 Koninklijke Philips N.V.: Key Financials

Figure 31 Koninklijke Philips N.V.: Segmental Revenue

Figure 32 Koninklijke Philips N.V.: Geographical Revenue

Figure 33 GE Healthcare: Key Financials

Figure 34 GE Healthcare: Segmental Revenue

Figure 35 GE Healthcare: Geographical Revenue

Figure 36 Stryker Corporation: Key Financials

Figure 37 Stryker Corporation: Segmental Revenue

Figure 38 Stryker Corporation: Geographical Revenue

Figure 39 Pfizer Inc.: Key Financials

Figure 40 Pfizer Inc.: Segmental Revenue

Figure 41 Pfizer Inc.: Geographical Revenue

Bottom of Form